GSK

• 2014 - 800 million doses of vaccines

  -80% in EDCs
• Creates amoxicillin for bacterial infections
• Zidovudine for HIV
• 13,000 in research and development

  -£3 billion per year on new medicines
• Research for HIV/AIDS, Makaria, TB, Ebola
• Caps drug prices in EDCs to 25% of UK price
• 20% of profits in each country to health infrastructure